Full Press Release Details
Lexaria Announces Product Update and International Expansion
Kelowna, BC October 8, 2015 - Lexaria Corp. (LXRP-OTCQB)
(LXX-CSE) (the "Company" or "Lexaria") is pleased to announce that the
manufacturing process to infuse active hemp oil utilizing Lexaria s patent
pending technology designed to provide higher bioavailability, has been
completed for both coffee and hot chocolate. Both products are currently under
packaging development and will be available for our customers soon.
Once the products have been delivered to our Phoenix
distribution facility, ViPova Coffee and Hot Chocolate will be available for
purchase both through our online store at www.vipova.com; and also at our
growing network of retail locations. Lexaria will announce when these two
products are available to be purchased.
Vipova tea is currently available at a growing number of
dispensaries across California. Contract sales efforts will also be made during
the next 3 months, for dispensaries in Nevada; Oregon and Colorado. These new
sales initiatives will continue to broaden the availability of ViPova products.
Lexaria has also determined that it will soon make ViPova and
Lexaria Energy products available for sale into the United Kingdom, due to a
favorable regulatory environment and to increased consumer demand. Initially,
sales will be made through the online store, but discussions are also underway
to enable local sales delivered from within the United Kingdom. Once that market
is entered, we also plan to offer the Lexaria Energy10 protein bars for sale as
well. The population of the United Kingdom is over 63 million. International
sales to the UK are expected to begin within 30 days, with local UK sales to be
announced when available.
Together, these initiatives will lead to more widespread access
to ViPova and Lexaria Energy products which should support increased sales
In vitro laboratory testing completed in August
determined that Lexaria s technology and formulation can result in cannabidiol
absorption rates as much as 499% higher than controls; an important advantage as
consumers increasingly search for products that offer less waste and higher
Lexaria, Corp. is a food sciences company focused on the
delivery of hemp oil compounds procured from legal, agricultural hemp seed oil,
through gourmet foods products based upon its proprietary infusion technologies. Lexaria Corp. is focused on
your comfort and well-being. Lexaria Corp s common shares are quoted in the USA
with the symbol LXRP and in Canada with the symbol LXX. To learn more about
Lexaria Corp. please visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to: that
it will soon make ViPova and Lexaria Energy products available for sale into the
United Kingdom. Such forward-looking statements are estimates reflecting the
Company's best judgment based upon current information and involve a number of
risks and uncertainties, and there can be no assurance that other factors will
not affect the accuracy of such forward-looking statements. Access to capital,
or lack thereof, is a major risk and there is no assurance that the Company will
be able to raise required working capital. Factors which could cause actual
results to differ materially from those estimated by the Company include, but
are not limited to, government regulation, managing and maintaining growth, the
effect of adverse publicity, litigation, competition, the patent application and
approval process and other factors which may be identified from time to time in
the Company's public announcements and filings. There is no assurance that the
medical marijuana, hemp oil sector, or alternative health businesses will
provide any benefit to Lexaria, or that the Company will experience any growth
through participation in these sectors. There is no assurance that existing
capital is sufficient for the Company's needs or that it will not need to
attempt to raise additional capital. There is no assurance that any planned
corporate activity, business venture, or initiative will be pursued, or if
pursued, will be successful. There is no assurance that any hemp oil or
cannabinoid-based product will promote, assist, or maintain any beneficial human
health conditions whatsoever. There is no assurance that the cannabinoid/lipid
infusion technology will provide any increase in bioavailability to any
individual person. There is no assurance that any patent application in the USA
or any other nation or under any treaty will result in the award of an actual
patent; nor that an award of any actual patent will protect against challenges
from unknown third parties. There is no assurance that any of Lexaria s
postulated uses, benefits, or advantages for the patent-pending technology will
in fact be realized in any manner or in any part. No statement herein has been
evaluated by the Food and Drug Administration (FDA). ViPovaTM
products and Lexaria Energy products are not intended to diagnose, treat, cure
or prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.